BRIEF-Mexico's Grupo Nutrisa To List 321.62 Mln Shares On Thursday At Reference Price Of 9.615 Pesos Per Share-March 2024-www.financetom.com

BRIEF-Mexico's Grupo Nutrisa To List 321.62 Mln Shares On Thursday At Reference Price Of 9.615 Pesos Per Share

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-Mexico's Grupo Nutrisa To List 321.62 Mln Shares On Thursday At Reference Price Of 9.615 Pesos Per Share

Sep 17, 2025 4:14 PM

Sept 17 (Reuters) - Grupo Nutrisa SAB de CV:

* MEXICO'S GRUPO NUTRISA TO LIST 321.62 MILLION SHARES ON

COUNTRY'S MAIN STOCK EXCHANGE ON THURSDAY AT REFERENCE PRICE OF

9.615 PESOS PER SHARE - FILING

Further company coverage:

(Reporting by Mexico City newsroom)

Previous page： RBC Previews This Week's GDP Data in Canada Next page： GSK Application to Expand Nucala Use to Treat Obstructive Pulmonary Disease Accepted for Review in Europe

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

RBC Previews This Week's GDP Data in Canada

Mar 24, 2025

07:49 AM EDT, 03/24/2025 (MT Newswires) -- United States tariff risks continue to cloud the outlook for Canada, but January's gross domestic product report should show further signs of life in an economy that broadly underperformed global peers in the previous two years, said RBC. Canada will release GDP data for January on Friday. The bank expects GDP increased 0.2%...

GSK Application to Expand Nucala Use to Treat Obstructive Pulmonary Disease Accepted for Review in Europe

Mar 24, 2025

07:46 AM EDT, 03/24/2025 (MT Newswires) -- GSK (GSK) said Monday the European Medicines Agency accepted for review its application to expand the use of Nucala to include maintenance treatment of chronic obstructive pulmonary disease with an eosinophilic phenotype. The application for the treatment, also known as mepolizumab, was backed by results from a phase 3 trial that showed a...

MAG Silver 2024 Profit Advances, to Pay First Dividend

Mar 24, 2025

07:47 AM EDT, 03/24/2025 (MT Newswires) -- MAG Silver ( MAG ) on Monday reported a higher profit for fiscal 2024 as the contribution from the Juanicipio Mine in Mexico increased and said it will pay its first dividend. Net income for fiscal 2024 rose to US$77.8 million, or US$0.75 per share, from US$47.8 million, or US$0.47 per share, last...

OraSure Technologies' Board Approves Up to $40 Million Stock Buyback Plan

Mar 24, 2025

07:49 AM EDT, 03/24/2025 (MT Newswires) -- OraSure Technologies ( OSUR ) said Monday its board authorized the buyback of up to $40 million of its common shares through the next 24 months. The company will finance the repurchases from cash on hand, OraSure ( OSUR ) added. Shares of the company rose 8% in recent Monday premarket activity. ...